Table 2 
RESULTS OF IMMUNOTHERAPY IN PATIENTS WITH ADVANCED CANCER (3/90) 
Treatment with IL-2 
Cancer Diagnosis 
Evaluable+ 
( number 
CR 
of patients) 
PR 
CR + PR 
(%) 
Renal 
60 
4 
8 
20% 
Melanoma 
41 
0 
10 
24% 
Colorectal 
12 
0 
0 
- 
Non Hodgkin's Lymphoma 
11 
0 
0 
- 
Breast 
3 
0 
0 
- 
Other-H- 
9 
0 
0 
- 
Total 
136 
4 
18 
17% 
+ Includes all treated patients except four 
that died of 
therapy. 
++Two patients each with 
ovary, pancreas, and 
hepatoma and brain 
uterine cancer. 
cancer; one 
each with 
sarcoma, lung 
[290] 
Recombinant DNA Research, Volume 14 
